9 employees
Vaxxilon AG is focused on the discovery and development of innovative synthetic carbohydrate vaccines.
2015
$1.4M
from 1 investors over 1 rounds
Vaxxilon AG raised $1.4M on August 20, 2019
Investors: CARB-X